StocksMarket.in

Dr Reddy’s Laboratories gains 9% on EIR from USFDA for Vizag facility

Dr Reddy’s Laboratories gains 9% on EIR from USFDA for Vizag facility
November 21
11:05 2017
Filed under
Uncategorized

Dr Reddy’s Laboratories gains 9% on EIR from USFDA for Vizag facility The company has received the establishment inspection (EIR) report from USFDA for formulations manufacturing facility at Duvvada, Vishakhapatnam.

Related Articles

Archives